Health Technology

Axonics® Expands Sacral Neuromodulation Intellectual Property Portfolio

Axonics® Expands

Axonics, Inc. a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that in the last twelve months, the United States Patent and Trademark Office has granted eight patents and allowed four patent applications related to the company’s sacral neuromodulation technology.

The patents and allowed applications are part of Axonics’ patent portfolio and represents technology internally developed by the company covering a range of subject matter that includes the Axonics external trial system, tined lead, implantable neurostimulator, clinician programmer, wireless charging system and patient remote control.

Axonics is committed to developing best-in-class technology to serve the unmet needs of the millions of adults suffering from incontinence. The volume, subject matter diversity, and breadth of these patents demonstrate the investment in innovation that Axonics continues to make in sacral neuromodulation technology,”

Raymond W. Cohen, chief executive officer

About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.

Axonics sacral neuromodulation (SNM) systems provide adults suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company’s best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics’ clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. 

Spotlight

Spotlight

Related News

Health Technology

Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program

PR Newswire | November 01, 2023

Abbott a global leader in heart health, announced the Abbott HeartMates program, a new initiative that will kick off with professional football player Damar Hamlin as its first ambassador. Experiencing a major heart-related incident can cause emotional distress and be an incredibly isolating experience.2 A group of individuals working together as a team can make all the difference to those affected and help them make a full comeback and live their fullest lives. The Abbott HeartMates program aims to create a community of support for people and caregivers impacted by heart conditions. The program will enable participants to share stories and receive emotional support as well as connect with others going through similar heart health journeys. Hamlin said. "After experiencing a cardiovascular event that changed my life, I know the power and importance of having an engaged team to lean on for mental and physical recovery. I'm partnering with Abbott to launch HeartMates because we share a vision to offer the support and encouragement I received after my incident, so others feel empowered to achieve their own comeback stories." [Source:PR Newswire] Building the HeartMates Team Abbott is inviting people who are committed to inspiring others through their heart health stories to join Hamlin on our HeartMates team. The team will be comprised of people directly or indirectly affected by a heart condition including cardiovascular patients, their caregivers, health care providers, friends and family. Team members will collaborate directly with Abbott and Hamlin as program ambassadors and promote the HeartMates community-building tenants to those impacted by heart conditions. Individuals who would like to nominate someone they know or submit themselves to be considered for the HeartMates team are encouraged to share their heart stories with Abbott and Hamlin via email at HeartMates@abbott.com. The inaugural HeartMates team will be drafted in early 2024. "At Abbott, we pour our hearts into developing innovative medical devices that empower people to come back from cardiovascular events," said Nadim Geloo, M.D., senior director of medical affairs in Abbott's Structural Heart business. "However, nobody makes a comeback alone. Our HeartMates program creates a community of support and resources for those navigating their heart health and embodies our unwavering commitment to ensuring that no one faces these challenges alone." Abbott and Hamlin are collaborating closely to further build the HeartMates community by meeting and hearing from people around the country impacted by cardiovascular events, as well as their caregivers. Hamlin and the Abbott team recently visited Maria Fareri Children's Hospital in Westchester, N.Y., to learn from caregivers and hear comeback stories directly from people who have experienced cardiac events.

Read More

Health Technology

GE HealthCare and Mass General Brigham Unite for AI Care Insights

GE HealthCare | September 08, 2023

​Leveraging operational AI and ML has the potential to unite providers and optimize the consolidation of data sets. During initial testing, the AI-driven algorithm demonstrated the ability to accurately forecast missed care opportunities, with success rates as high as 96%. AI and machine learning insights strategically improve productivity and administrative efficiency at both departmental and enterprise levels. In 2017, GE HealthCare and Mass General Brigham embarked on a ten-year partnership focused on AI innovation in diagnostics and treatments. GE HealthCare and Mass General Brigham have unveiled the joint development of an AI algorithm. This algorithm is designed to enhance operational efficiency and productivity in healthcare. The maiden AI application stemming from this collaboration is the 'schedule predictions dashboard' integrated into the Radiology Operations Module (ROM), a digital imaging tool readily available for deployment by healthcare institutions. Its primary objective encompasses the optimization of scheduling procedures, cost reduction, and alleviating administrative burdens placed on healthcare providers. By doing so, ROM liberates valuable time, permitting clinicians to invest more of their efforts into fostering and strengthening the clinician-patient relationship. Amid a vast sea of data and the demanding responsibilities that often divert healthcare providers from patient care, Parminder Bhatia, Chief AI Officer of GE HealthCare, described the collaboration with Mass General Brigham as groundbreaking. He added that they combine unique datasets and utilize cutting-edge machine learning techniques, harnessing the synergy of clinical and technical expertise to usher in unprecedented advancements in healthcare. Keith Dreyer, DO, Ph.D., Chief Data Science Officer, Mass General Brigham, remarked, This technology has the potential to reduce burnout and allow physicians to spend more time with patients, which may ultimately lead to better outcomes. [Source: Business Wire] Operational AI-enabled tools can tackle challenges that frequently jeopardize patient care, including the cost of healthcare and inefficiencies within hospitals. When a patient misses an appointment, neglects to schedule a follow-up, or arrives late, collectively called missed care opportunities (MCO), the repercussions can be substantial. The algorithm developed in collaboration is designed to forecast MCO and late arrivals. This initiative aims to enhance operational flexibility, streamline administrative processes, elevate patient satisfaction, and more effectively accommodate urgent, inpatient, or walk-in appointments. GE HealthCare, a global leader in medical technology, pharmaceutical diagnostics, and digital solutions, focuses on delivering integrated solutions, services, and data analytics to enhance hospital efficiency, support clinicians, improve therapy precision, and promote patient well-being. With over a century of service to patients and healthcare providers, the company advances personalized, connected, and compassionate care through imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics.

Read More

Healthcare Analytics

Hartford HealthCare and Walgreens partner to provide health clinics that improve access to care

PR Newswire | October 26, 2023

Walgreens and Hartford HealthCare will add health clinics to select Walgreens locations in Connecticut, advancing a unique retail health model based on convenience, access to care, affordability and health equity. This is Walgreens first retail clinic collaboration with a health system in New England. Under a clinical collaboration agreement, five clinics operated by Hartford HealthCare medical providers will be added to Walgreens locations, including 340 Flanders Road, in East Lyme (at Flanders Four Corners); 2 Shaker Road, in Enfield; 235 Main Street, in Norwalk; and 203 Kennedy Drive, in Putnam. One additional location will be announced in the coming months. Hartford HealthCare at Walgreens clinics are scheduled to open within a year and will offer primary care, screenings, vaccinations, confidential telehealth services and more, seven days per week by appointment or walk-in. The collaboration is based on the organizations' shared vision to improve access to care, reduce healthcare costs and offer convenient access to essential primary care and pharmacy services. The locations will offer consumers a convenient destination to access both Walgreens experience in community retail health and pharmacy operations and Hartford HealthCare's expertise in delivering patient care, employing highly qualified medical professionals, and operating health centers. Hartford HealthCare at Walgreens will combine in-person care from a medical professional and, when needed, confidential in-store virtual care. For ease of access, an employee of Hartford HealthCare Medical Group will provide patient registration and point-of-care services, while a Medical Group primary care provider will offer private virtual care visits, including referrals as needed. Rounding out the experience, patients will have convenient access to Walgreens pharmacy and retail services. said Jeffrey A. Flaks, President and Chief Executive Officer of Hartford HealthCare Hartford HealthCare is intent on changing the way healthcare is delivered, and this collaboration with Walgreens is another example of the variety of convenient offerings and care settings we are adding. Our organizations are working together to combine resources and best practices to create an innovative retail health environment that meets consumers' needs and exceeds their expectations. [Source:PR Newswire] "Walgreens is committed to providing patients the care they need when and how it is most convenient for them," said John Driscoll, executive vice president and president, U.S. Healthcare, Walgreens Boots Alliance. "Through this special collaboration with Hartford HealthCare, we can help keep patients more connected to high-quality care and foster long-term relationships and behaviors that help patients get and stay healthy." Together, Walgreens and Hartford HealthCare will provide one-stop convenience — a community health destination offering a health clinic, pharmacy services and retail all in one location. Patients can see their provider, pick up their medications and go shopping at their neighborhood Wcapitalalgreens. Nearly 80% of Americans live within five miles of a Walgreens store.

Read More